1. No category

Transparency Market
Research
Peptide Therapeutics Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast 2014 - 2020
Published Date
2015-04-27
104 Page Report
Buy Now
Request Sample
Press Release
Peptide Therapeutics Market Expected to Reach USD 23.7 Billion
Globally in 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Peptide Therapeutics Market
REPORT DESCRIPTION
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2014 – 2020
The global peptide therapeutics market report provides detailed analysis, market size, and
forecast for therapeutic peptides approved for various indications. The market is studied from
four major perspectives: applications, route of administration, marketing status, and geography.
Application segments of the global peptide therapeutics market have been further subsegmented by major branded peptide drugs approved by regulatory authorities across the globe.
Various applications considered in the report include metabolic disorders, hematological
disorders, cancer, cardiovascular disorders, central nervous system disorders, infection,
gastrointestinal disorders, respiratory disorders, acromegaly, and others. Market size and
forecast for leading drugs such as Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza,
and Zoladex has been included along with in-depth market analysis. Segmentation by marketing
status explains the impact of generic drugs on the overall peptide therapeutics market. Further,
market segmentation of peptide drugs by route of administration provides quantitative insights
into the growing demand for convenient methods for peptide drug administration. Details on
peptide drug approvals, patent expiry, mergers, acquisitions, strategic agreements, disease
prevalence and other major events have been included in respective market segments.
Browse the full Peptide Therapeutics Market Report at :
http://www.transparencymarketresearch.com/peptide-therapeuticsmarket.html
The global peptide therapeutics market report provides market estimation and forecast for more
than fifteen branded peptide drugs in the market. Further, the market is also segmented by
major geographical regions, which include North America, Europe, Asia Pacific and Rest of the
World. A list of pipeline drugs has also been provided in the report. This list includes potential
peptide drugs in phases I, II, and III of clinical development.
Transparency Market Research
2
Peptide Therapeutics Market
Emerging trends in global peptide API production, such as development of new peptide API
production technologies and strategic agreements in peptide API production have been
discussed. The report also profiles key peptide API suppliers. An overview of regulatory policies
has also been provided in the global peptide therapeutics market report. Based on our in-depth
analysis and comprehensive market study, key factors driving and restraining the market have
been discussed. A detailed event impact analysis considers regulatory approvals, patent expiry
of major drugs, drug recalls and other factors in the peptide therapeutics market. The research
study also incorporates the competitive scenario in these regions, where market share of seven
major players in 2013 has also been provided. Relevant recommendations have been provided
for new entrants as well as existing market players to help them establish a strong presence in
the market and increase their share. Fifteen major players have been profiled which include
Amgen, Inc., AstraZeneca plc, Bachem Holding AG, CordenPharma International GmbH, Eli Lilly &
Co., Ipsen S.A., Lonza, Inc., Merck & Co., Novartis AG, Novo Nordisk A/S, PolyPeptide Group,
Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical
Industries Limited. The 104 pages global peptide therapeutics market report includes 30 figures
and charts, and 14 tables.
Browse the full Peptide Therapeutics Market press release at :
http://www.transparencymarketresearch.com/pressrelease/peptidetherapeutics-market.htm
Market size and forecast in terms of USD million for each segment in the global peptide
therapeutics market has been provided for the period 2012 to 2020, considering 2012 and 2013
as the base years. The report also provides the compounded annual growth rate (CAGR %) for
each market segment for the forecast period 2014 to 2020. The peptide therapeutics market has
been estimated using a bottom-up approach, where market size estimates for each drug have
been summed-up to arrive at the total market size. Market forecasts have been derived
considering the effect of generic drug approvals, drug recalls, disease prevalence, patent term
extension, box warning and various other factors. Inputs from industry experts and key opinion
leaders have validated and further refined our market estimates.
Transparency Market Research
3
Peptide Therapeutics Market
Get Free Sample Report Peptide Therapeutics Market :
http://www.transparencymarketresearch.com/sample/sample.php?
flag=s&rep_id=418
The global peptide therapeutics market has been segmented as below:
Global Peptide Therapeutics Market, by Application
Cancer
Zoladex (goserelin)
Velcade (bortezomib)
Lupron/ Enantone/ Eligard (leuprorelin)
Others
Cardiovascular
Angiomax (bivalirudin)
Integrilin (eptifibatide)
Transparency Market Research
4
Peptide Therapeutics Market
Central Nervous System
Copaxone (glatiramer)
Metabolic Disorders
Victoza (liraglutide)
Byetta (exenatide)
Others
Infection
Incivek (telaprevir)
Victrelis (boceprevir)
Hematological Disorders
Firazyr (icatibant)
Transparency Market Research
5
Peptide Therapeutics Market
Kalbitor (ecallantide)
Gastrointestinal Disorders
Gattex (teduglutide)
Linzess (linaclotide)
Respiratory Disorders
Acromegaly
Other Applications
Global Peptide Therapeutics Market, by Route of Administration
Parenteral
Oral
Global Peptide Therapeutics Market, by Marketing Status
Branded
Transparency Market Research
6
Peptide Therapeutics Market
Generic
Global Peptide Therapeutics Market, by Geography
North America
Europe
Asia Pacific
Rest of the World
TABLE OF CONTENT
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
1.5 Assumptions and Stipulations
Transparency Market Research
7
Peptide Therapeutics Market
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Peptide Therapeutics Market (2013 & 2020)
2.2 Global Peptide Therapeutics Market, by Applications, 2013 (USD Million)
Chapter 3 Global Peptide Therapeutics Market Overview
3.1 Introduction
3.2 Emerging Trends in Peptide Therapeutics Market
3.2.1 Trends in Peptide Manufacturing Technology
3.2.2 Trends in Peptide API Supply
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increase in cancer and diabetes patient population to propel the growth of new peptides
3.3.1.2 Rich R&D pipeline of peptide drugs is expected to drive growth
3.3.1.3 Technological advancements have reduced total production cost of peptides
3.3.2 Restraints
3.3.2.1 Increasing complexity of peptides is a huge challenge for API manufacturers
3.3.2.2 Lack of regulatory standards
3.3.3 Opportunities
3.3.3.1 Generic peptides market to flourish with patent cliff expected during the forecast period
3.3.3.2 Biotech firms collaborating with large pharmaceutical companies to explore further growth
3.4 Regulatory Scenario
Transparency Market Research
8
Peptide Therapeutics Market
3.5 Porter’s Five Forces Analysis: Global Peptide Therapeutics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyer
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Event Impact Analysis
3.6.1 Event Impact Analysis: Global Peptide Therapeutics Market
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis of Global Peptide Therapeutics Market, by Geography, 2013
3.8 Market Share Analysis
Chapter 4 Global Peptide Therapeutics Market, by Applications
4.1 Introduction
4.1.1 Global Peptide Therapeutics Market Revenue, by Application, 2012 – 2020 (USD Million)
4.2 Cancer
4.2.1 Global Cancer Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.2.2 Zoladex (goserelin)
4.2.3 Velcade (bortezomib)
4.2.4 Lupron/ Enantone/ Eligard (leuprorelin)
4.2.5 Others
Transparency Market Research
9
Peptide Therapeutics Market
4.3 Cardiovascular
4.3.1 Global Cardiovascular Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD
Million)
4.3.2 Angiomax (bivalirudin)
4.3.3 Integrilin (eptifibatide)
4.4 Central Nervous System
4.4.1 Global Central Nervous System Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.4.2 Copaxone (glatiramer)
4.5 Metabolic Disorders
4.5.1 Global Metabolic Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.5.2 Victoza (liraglutide)
4.5.3 Byetta (exenatide)
4.5.4 Others
4.6 Infection
4.6.1 Global Infection Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.6.2 Incivek (telaprevir)
4.6.3 Victrelis (boceprevir)
4.7 Hematological Disorders
4.7.1 Global Hematological Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.7.2 Firazyr (icatibant)
4.7.3 Kalbitor (ecallantide)
Transparency Market Research
10
Peptide Therapeutics Market
4.8 Gastrointestinal Disorders
4.8.1 Global Gastrointestinal Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD
Million)
4.8.2 Gattex (teduglutide)
4.8.3 Linzess (linaclotide)
4.9 Respiratory Disorders
4.9.1 Global Respiratory Disorders Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
4.10 Acromegaly
4.10.1 Global Acromegaly Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
4.11 Other Applications
4.11.1 Global Other Applications Peptide Therapeutics market Revenue, 2012 - 2020 (USD Million)
Chapter 5 Global Peptide Therapeutics Market, by Route of Administration
5.1 Introduction
5.1.1 Global Peptide Therapeutics Market Revenue, by Route of Administration, 2012 - 2020 (USD
Million)
5.2 Parenteral Route of Administration
5.2.1 Global Peptide Therapeutics Market Revenue, by Parenteral Route of Administration, 2012 - 2020
(USD Million)
5.3 Oral Route of Administration
5.3.1 Global Peptide Therapeutics Market Revenue, by Oral Route of Administration, 2012 - 2020 (USD
Million)
Transparency Market Research
11
Peptide Therapeutics Market
Chapter 6 Global Peptide Therapeutics Market, by Marketing Status
6.1 Introduction
6.1.1 Global Peptide Therapeutics Market Revenue, by Marketing Status, 2012 - 2020 (USD Million)
6.2 Branded Peptide Therapeutics
6.2.1 Global Branded Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
6.3 Generic Peptide Therapeutics
6.3.1 Global Generic Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
Chapter 7 Global Peptide Therapeutics Pipeline Overview
7.1 Introduction
7.1.1 Global Peptide Therapeutics Pipeline Overview
Chapter 8 Global Peptide Therapeutics Market, by Geography
8.1 Introduction
8.1.1 Global Peptide Therapeutics Market Revenue, by Geography, 2012 - 2020 (USD Million)
8.2 North America
8.2.1 North America Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
8.3 Europe
8.3.1 Europe Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
Transparency Market Research
12
Peptide Therapeutics Market
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
8.5 Rest of the World
8.5.1 Rest of the World Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
Chapter 9 Recommendations
9.1 Rigorous research and development (R&D) would yield new products
9.2 Facility expansion in emerging economies
9.3 Rapid inorganic growth through acquisitions
Chapter 10 Company Profiles
10.1 Amgen, Inc.
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 AstraZeneca plc
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Product Portfolio
Transparency Market Research
13
Peptide Therapeutics Market
10.2.4 Business Strategies
10.2.5 Recent Developments
10.3 Bachem Holding AG
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 CordenPharma International GmbH
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Developments
10.5 Eli Lilly and Company
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Ipsen S.A.
Transparency Market Research
14
Peptide Therapeutics Market
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 Lonza Group Ltd.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.7.5 Recent Developments
10.8 Merck & Co., Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
10.9 Novartis AG
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
Transparency Market Research
15
Peptide Therapeutics Market
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 Novo Nordisk A/S
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 PolyPeptide Group
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 Roche Holdings AG
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Sanofi
Transparency Market Research
16
Peptide Therapeutics Market
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 Takeda Pharmaceutical Company Limited
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments
10.15 Teva Pharmaceutical Industries Ltd.
10.15.1 Company Overview
10.15.2 Financial Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.15.5 Recent Developments
List of Figures
FIG. 1 Peptide Therapeutics Market Segmentation
FIG. 2 Global Peptide Therapeutics Market, by Applications, 2013 (USD Million)
Transparency Market Research
17
Peptide Therapeutics Market
FIG. 3 Porter’s Five Forces Analysis: Global Peptide Therapeutics Market
FIG. 4
FIG. 5 Market Attractiveness Analysis of Global Peptide Therapeutics Market, by Geography, 2013
FIG. 6 Market Share Analysis of Global Peptide Therapeutics Market, by Key Players, 2013 (Value %)
FIG. 7 Global Central Nervous System Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
FIG. 8 Global Respiratory Disorders Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 9 Global Other Applications Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 10 Global Peptide Therapeutics Market Revenue, by Parenteral Route of Administration, 2012 - 2020
(USD Million)
FIG. 11 Global Peptide Therapeutics Market Revenue, by Oral Route of Administration, 2012 - 2020 (USD
Million)
FIG. 12 Global Branded Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global Generic Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 North America Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Europe Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Asia Pacific Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Rest of the World Peptide Therapeutics Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Amgen, Inc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 19 AstraZeneca plc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 20 Bachem Holding AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 21 Eli Lilly and Company: Annual Revenue, 2011 – 2013 (USD Million)
Transparency Market Research
18
Peptide Therapeutics Market
FIG. 22 Ipsen S.A.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Lonza Group Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Merck & Co., Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Novartis AG Annual Revenue: 2011 – 2013 (USD Million)
FIG. 26 Novo Nordisk A/S Annual Revenue: 2011 – 2013 (USD Million)
FIG. 27 Roche Holdings AG: Annual Revenue: 2011 – 2013 (USD Million)
FIG. 28 Sanofi: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Takeda Pharmaceutical Co. Ltd.: Annual Revenue: 2011 – 2013 (USD Million)
FIG. 30 Teva Pharmaceutical Co. Ltd.: Annual Revenue: 2011 – 2013 (USD Million)
List of Tables
TABLE 1 Market Snapshot: Global Peptide Therapeutics Market (2013 & 2020)
TABLE 2 Event Impact Analysis: Global Peptide Therapeutics Market
TABLE 3 Global Peptide Therapeutics Market Revenue, by Application, 2012 – 2020 (USD Million)
TABLE 4 Global Cancer Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 5 Global Cardiovascular Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 6 Global Metabolic Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 7 Global Infection Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 8 Global Hematological Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 9 Global Gastrointestinal Disorders Peptide Therapeutics Market Revenue, 2012 – 2020 (USD
Million)
Transparency Market Research
19
Peptide Therapeutics Market
TABLE 10 Global Acromegaly Peptide Therapeutics Market Revenue, 2012 – 2020 (USD Million)
TABLE 11 Global Peptide Therapeutics Market Revenue, by Route of Administration, 2012 - 2020 (USD
Million)
TABLE 12 Global Peptide Therapeutics Market Revenue, by Marketing Status, 2012 - 2020 (USD Million)
TABLE 13 Global Peptide Therapeutics Market Pipeline Overview
TABLE 14 Global Peptide Therapeutics Market Revenue, by Geography, 2012 - 2020 (USD Million)
Browse All Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Contact
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
Transparency Market Research
20
Peptide Therapeutics Market
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse The Market Research Blog :
http://researchandreports.wordpress.com/ http://www.transparencymarketresearch.com
Transparency Market Research
21